Status:
COMPLETED
Evaluation of Endobronchial Ultrasound (EBUS) for Staging Lung Cancer
Lead Sponsor:
Ottawa Hospital Research Institute
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This study will compare two different methods of staging lung cancer to determine whether endobronchial ultrasound (EBUS) staging of mediastinal lymph nodes will provide good diagnostic yield in detec...
Eligibility Criteria
Inclusion
- Patients, \> 18 years of age,
- Gender- Males and Female
- Diagnosis of Non Small Cell Lung Cancer.
- Patients who have consented on an Ottawa Hospital consent form to undergo a mediastinoscopy procedure or EBUS-TBNA, and a Positron emission tomography (PET) of the chest for lung cancer staging.
Exclusion
- Females who are pregnant (or found to be pregnant) during the course of this research study.
- Patients who do not provide their Ottawa Hospital consent to undergo a staging bronchoscopy , cervical mediastinoscopy or EBUS-TBNA.
Key Trial Info
Start Date :
June 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2018
Estimated Enrollment :
37 Patients enrolled
Trial Details
Trial ID
NCT01799980
Start Date
June 1 2012
End Date
December 1 2018
Last Update
March 21 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ottawa Hospital Research Institute
Ottawa, Ontario, Canada, K1H8L6